We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.65B
1-Year Est. Return 203.21%
This Fund
S&P 500
This Quarter Est. Return
+42.6%
1 Year Est. Return
+203.21%
3 Year Est. Return
+364.25%
5 Year Est. Return
+595.91%
10 Year Est. Return
+10,683%
AUM
$1.65B
AUM Growth
+$529M
Cap. Flow
+$107M
Cap. Flow %
6.48%
Top 10 Hldgs %
60.74%
Holding
37
New
2
Increased
17
Reduced
12
Closed
6

Top Buys

Rank Stock Value
1
ELVN icon
Enliven Therapeutics
ELVN
+$49.2M
2
SIBN icon
SI-BONE Inc
SIBN
+$39.6M
3
TNDM icon
Tandem Diabetes Care
TNDM
+$36.1M
4
APGE
Apogee Therapeutics
APGE
+$31.9M
5
WGS icon
GeneDx Holdings
WGS
+$30.7M

Top Sells

Rank Stock Value
1
CNTA
Centessa Pharmaceuticals
CNTA
+$62M
2
AXGN icon
Axogen
AXGN
+$50.6M
3
PVLA
Palvella Therapeutics
PVLA
+$25.4M
4
WVE icon
Wave Life Sciences
WVE
+$13.4M
5
VERA icon
Vera Therapeutics
VERA
+$12.6M

Sector Composition

Rank Sector Weight
1 Healthcare 100%

No holdings matched the selected filter criteria.

1 2

Similar funds

AAM
Aureus Asset Management Boston, Massachusetts $1.65B AUM 26.32% 1-Year Est. Return
NPA
Nichols & Pratt Advisers Boston, Massachusetts $1.65B AUM 22.9% 1-Year Est. Return
SOS
Silver Oak Securities Jackson, Tennessee $1.65B AUM 29.37% 1-Year Est. Return
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return
BFO
Boston Family Office Boston, Massachusetts $1.65B AUM 18.1% 1-Year Est. Return
AAG
Armstrong Advisory Group Needham, Massachusetts $1.64B AUM 19.37% 1-Year Est. Return
MCIL
MFF Capital Investments Ltd Sydney $1.65B AUM
TIM
Triodos Investment Management Driebergen-Rijsenburg, Netherlands $1.64B AUM 37.98% 1-Year Est. Return

First Light Asset Management's Q2 2026 Portfolio in Review

As of Q2 2026, First Light Asset Management held 37 positions worth $1.65B, up 47% from $1.12B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

First Light Asset Management deployed $107M of net new capital in Q2 2026, opening 2 new positions and adding to 17 existing holdings. Its largest new stake was Trevi Therapeutics: 2,097,215 shares worth $39.1M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was Axogen, an estimated $50.6M trimmed.

  • First Light Asset Management's largest Q2 2026 buy was Trevi Therapeutics: 2,097,215 shares worth $39.1M.
  • First Light Asset Management added most to Enliven Therapeutics in Q2 2026, an estimated $49.2M increase.
  • First Light Asset Management's biggest Q2 2026 reduction was Axogen, cutting an estimated $50.6M.
  • First Light Asset Management fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $62M.
  • First Light Asset Management's ten largest holdings make up 61% of its $1.65B portfolio in Q2 2026.
  • First Light Asset Management opened 2 new positions and closed 6 in Q2 2026.
  • First Light Asset Management's portfolio value rose 47% quarter-over-quarter to $1.65B.

Based on First Light Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.